Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
Jodi M. Carter(University of Alberta), E. Aubrey Thompson(Mayo Clinic in Florida), Douglas Hinerfeld, Fergus J. Couch(Mayo Clinic), Minetta C. Liu(Mayo Clinic), Keith L. Knutson(WinnMed), Judy C. Boughey(Mayo Clinic in Arizona), David Zahrieh(Mayo Clinic in Florida), Saranya Chumsri(Jacksonville College), Ji Shi(Mayo Clinic in Florida), Edith A. Perez(Unknown), Henrik Lindman(Uppsala University), Roberto A. Leon‐Ferre(Mayo Clinic), Jennifer M. Kachergus(Norwegian University of Science and Technology), Sarah Warren(Nanostring Technologies (United States)), James N. Ingle(Mayo Clinic), Krishna R. Kalari(Mayo Clinic in Florida), Kathleen Tenner(Mayo Clinic in Florida), David W. Hillman(Mayo Clinic in Florida), Heikki Joensuu(Orion Corporation (Finland)), Yi Liu(Boston Children's Hospital), Xue Wang(Mayo Clinic in Florida), Yaohua Ma(Mayo Clinic in Florida), Heather Ann Brauer(Gates Foundation), David Henderson(University of Arizona), Matthew P. Goetz(Mayo Clinic)
Cited by 44
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k